Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126729281 | 12672928 | 1 | I | 20160815 | 20160822 | 20160822 | EXP | DE-ELI_LILLY_AND_COMPANY-DE201608007483 | ELI LILLY AND CO | 42.00 | YR | F | Y | 0.00000 | 20160822 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126729281 | 12672928 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Oral | 10 MG, QD | U | U | 20592 | 10 | MG | TABLET | QD | ||||
| 126729281 | 12672928 | 2 | C | SAB SIMPLEX /00159501/ | 2 | Unknown | UNK, UNKNOWN | U | 0 | ||||||||||
| 126729281 | 12672928 | 3 | C | COTAZYM /00014701/ | 2 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126729281 | 12672928 | 1 | Mental disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126729281 | 12672928 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126729281 | 12672928 | Dizziness | |
| 126729281 | 12672928 | Ear pain | |
| 126729281 | 12672928 | Pancreatic disorder | |
| 126729281 | 12672928 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |